000 01255 a2200349 4500
005 20250517054352.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.5460
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYin, Weijiao
245 0 0 _aEfficacy and safety of capecitabine-based first-line chemotherapy in advanced or metastatic breast cancer: a meta-analysis of randomised controlled trials.
_h[electronic resource]
260 _bOncotarget
_cNov 2015
300 _a39365-72 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aAntimetabolites, Antineoplastic
_xadverse effects
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCapecitabine
_xadverse effects
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
700 1 _aPei, Guangsheng
700 1 _aLiu, Gang
700 1 _aHuang, Li
700 1 _aGao, Shegan
700 1 _aFeng, Xiaoshan
773 0 _tOncotarget
_gvol. 6
_gno. 36
_gp. 39365-72
856 4 0 _uhttps://doi.org/10.18632/oncotarget.5460
_zAvailable from publisher's website
999 _c25309645
_d25309645